This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the Vanguard Health Care ETF (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
UnitedHealth Rises on Q2 Earnings Beat: ETFs to Gain
by Sweta Killa
UnitedHealth Group (UNH) reported better-than-expected second-quarter 2024 results as it breezed past the Zacks Consensus Estimate on both earnings and revenues.
5 Favorite Sectors This Earnings Season and Their ETFs
by Sweta Killa
Of the 16 Zacks sectors, nine are expected to post earnings growth in the second quarter, with the strongest gains in the Technology sector (15.8%).
2 Sector ETFs & Stocks to Gain Despite Soft June Jobs Data
by Sanghamitra Saha
The U.S. economy added 206,000 jobs in June 2024, slightly below a downwardly revised 218,000 in May and above forecasts of 190,000.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
by Zacks Equity Research
Sector ETF report for RSPH
Should ALPS Equal Sector Weight ETF (EQL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EQL
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
3 Sector ETFs & Stocks Likely to Benefit On Solid Jobs Data
by Sanghamitra Saha
The US economy added 272, 000 jobs in May 2024, the maximum in five months, compared to a downwardly revised 165,000 in April, and well above forecasts of 185,000.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
FOMO Rally Gains Momentum? ETF Strategies to Play
by Sanghamitra Saha
Per the legendary investor John Hussman -- famous for predicting the 2000 and 2008 crashes, the latest stock rally is ingrained in the extreme fear of missing out. This FOMO rally may fizzle if the consensus view starts changing and valuation gets too ripe.
Should You Invest in the iShares U.S. Healthcare ETF (IYH)?
by Zacks Equity Research
Sector ETF report for IYH
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
by Zacks Equity Research
Sector ETF report for XLV
Is ALPS Equal Sector Weight ETF (EQL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for EQL
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Should You Invest in the Vanguard Health Care ETF (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
Inflation Cools in April: 5 Sector ETFs & Stocks to Thrive
by Sanghamitra Saha
In April, inflationary pressures showed signs of easing. However, a few sectors and stocks that may gain in the near term as the price gains remained steady in those business areas.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
by Zacks Equity Research
Sector ETF report for RSPH
4 Sector ETFs & Stocks Likely to Benefit Despite Soft Jobs Data
by Sanghamitra Saha
The U.S. economy added 175, 000 jobs in April, well below Wall Street expectations of 240, 000.
ETF Asset Report of April
by Sanghamitra Saha
Performance-wise April became the worst month of 2024 for Wall Street. However, the S&P 500, the total stock market and the total bond market ETFs witnessed maximum asset accumulation in the month.
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
by Sweta Killa
Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.
Should ALPS Equal Sector Weight ETF (EQL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EQL
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
by Sweta Killa
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Beyond "Big Six:" Why Choose Non-Cyclical Sector ETFs?
by Sanghamitra Saha
UBS pointed out that rapid earnings growth recorded by the big six tech giants over the past year is now ebbing. Hence, this could be the time to bet on non-cyclical sectors.
UnitedHealth Rises on Q1 Earnings Beat: ETFs to Gain
by Sweta Killa
UnitedHealth Group (UNH) breezed past the Zacks Consensus Estimate on both earnings and revenues.